In reply to Mr. Masse, there are really three things that I'm concerned about. One is reinstating the list that was approved back in 2004. Secondly, I am concerned with making sure that any additions to that list will have Health Canada approval. Thirdly, I am concerned that the process is one whereby new medications can be added. You say it's a cumbersome process. I can't speak to that.
I think it's important to make sure that any medication that Canada is going to authorize under CAMR is looked at and, in particular, that it has Health Canada approval. That really was my intent in making the amendments that I proposed.